Cargando…
Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal
Fingolimod (FTY) is a disease modifying therapy for relapsing remitting multiple sclerosis (RRMS) which can lead to severe lymphopenia requiring therapy discontinuation in order to avoid adverse events. However, this can result in severe disease reactivation occasionally presenting with tumefactive...
Autores principales: | Koska, Valeria, Förster, Moritz, Brouzou, Katja, Arat, Ercan, Albrecht, Philipp, Aktas, Orhan, Küry, Patrick, Meuth, Sven G., Kremer, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585856/ https://www.ncbi.nlm.nih.gov/pubmed/34777236 http://dx.doi.org/10.3389/fneur.2021.785180 |
Ejemplares similares
-
Case Report: Successful Stabilization of Marburg Variant Multiple Sclerosis With Ocrelizumab Following High-Dose Cyclophosphamide Rescue
por: Koska, Valeria, et al.
Publicado: (2021) -
Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
Publicado: (2018) -
Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
por: Novi, Giovanni, et al.
Publicado: (2017) -
Case Report: Severe rebound after withdrawal of fingolimod in a patient with neuromyelitis optica spectrum disorder
por: Lin, Wei, et al.
Publicado: (2023) -
Risk factors for fingolimod-induced lymphopenia in multiple sclerosis
por: Ohtani, Ryohei, et al.
Publicado: (2018)